USFDA gives nod to Pfizer’s drug therapy for patients with Hemophilia – Healthcare News
The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from Hemophilia A or B. According to...
The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from Hemophilia A or B. According to...
The notion of mindfulness is key to developing ideas that can address how healthcare service providers (e.g., clinicians) can effectively...
Four-year-old Trey Lowman is fighting an aggressive brain cancer. His mom said when her son is with their music therapist,...
Interference by insurers is driving mental health care providers to flee networks. It makes treatment hard to find. Some states...
As HCA Healthcare recognizes Mental Health Awareness Month this May, learn how we’re supporting the mental well-being of our colleagues,...
Months after Kaiser Permanente reached a sweeping agreement with state regulators to improve its mental health services, the healthcare giant...
A recent study published in March 2024 in NEJM Evidence, led by senior author Marco Ruella, M.D., assistant professor of...
(SACRAMENTO) The teams at UC Davis Medical Center and UC Davis Children’s Hospital have a scentsational new option to reduce...
Cancer patients in the UK are receiving a new therapeutic to help their bodies recognise and fight cancer cells as...